Basic Information
| RNALocate ID: | RLID:11001960 |
| RNA Symbol: | hsa-miR-186-5p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-miR-186 |
| RNA ID: | miRBase:MIMAT0000456 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22849433 |
| Tissue/Cell Line: | HEK-293T cells |
| Method: | Next-generation RNA sequencing |
| Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001846 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001847 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001848 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001849 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11001953 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001954 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001955 | Exosome | Breast milk | 22211110 |
| RLID:11001956 | Exosome | Brain tissue | 23382797 |
| RLID:11001957 | Exosome | Plasma | 23663360 |
| RLID:11001958 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001959 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11001961 | Microvesicle | Plasma | 23077538 |
| RLID:11001962 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000101 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000384 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-186-5p | Diffuse large b cell lymphoma | MNDR-E-MI-21154 |
| MNDR | hsa-miR-186-5p | Medulloblastoma | MNDR-E-MI-21155 |
| MNDR | hsa-miR-186-5p | Lymphoma | MNDR-E-MI-21156 |
| MNDR | hsa-miR-186-5p | Dermatomyositis | MNDR-E-MI-21157 |
| MNDR | hsa-miR-186-5p | Prostate cancer | MNDR-E-MI-21158 |
| MNDR | hsa-miR-186-5p | Gastric cancer | MNDR-E-MI-21159 |
| MNDR | hsa-miR-186-5p | Alzheimer disease | MNDR-E-MI-21160 |
| MNDR | hsa-miR-186-5p | Intracranial aneurysm | MNDR-E-MI-21161 |
| MNDR | hsa-miR-186-5p | Esophageal carcinoma | MNDR-E-MI-21162 |
| MNDR | hsa-miR-186-5p | Dysautonomia familial | MNDR-E-MI-21163 |
| MNDR | hsa-miR-186-5p | Polycystic ovary syndrome | MNDR-E-MI-21164 |
| MNDR | hsa-miR-186-5p | Leukemia | MNDR-E-MI-21165 |
| MNDR | hsa-miR-186-5p | Cardiovascular disease | MNDR-E-MI-21166 |
| MNDR | hsa-miR-186-5p | Focal segmental glomerulosclerosis | MNDR-E-MI-21167 |
| MNDR | hsa-miR-186-5p | Lung cancer | MNDR-E-MI-21168 |
| MNDR | hsa-miR-186-5p | Down syndrome | MNDR-E-MI-21169 |
| MNDR | hsa-miR-186-5p | Parkinson disease | MNDR-E-MI-21170 |
| MNDR | hsa-miR-186-5p | Breast cancer | MNDR-E-MI-21171 |
| MNDR | hsa-miR-186-5p | Pituitary neoplasms | MNDR-E-MI-21172 |
| MNDR | hsa-miR-186-5p | Pancreatic cancer | MNDR-E-MI-21173 |
| MNDR | hsa-miR-186-5p | Melanoma | MNDR-E-MI-21174 |
| MNDR | hsa-miR-186-5p | Rectum adenocarcinoma | MNDR-E-MI-21175 |
| MNDR | hsa-miR-186-5p | Colon cancer | MNDR-E-MI-21176 |
| MNDR | hsa-miR-186-5p | Colon adenocarcinoma | MNDR-E-MI-21177 |
| MNDR | hsa-miR-186-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21178 |
| MNDR | hsa-miR-186-5p | Familial ovarian cancer | MNDR-E-MI-21179 |
| MNDR | hsa-miR-186-5p | Prostate adenocarcinoma | MNDR-E-MI-21180 |
| MNDR | hsa-miR-186-5p | Kidney cancer | MNDR-E-MI-21181 |
| MNDR | hsa-miR-186-5p | Carcinoma ductal breast | MNDR-E-MI-21182 |
| MNDR | hsa-miR-186-5p | Glioblastoma | MNDR-E-MI-21183 |
| MNDR | hsa-miR-186-5p | Glioma | MNDR-E-MI-21184 |
| MNDR | hsa-miR-186-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-21185 |
| MNDR | hsa-miR-186-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21186 |
| MNDR | hsa-miR-186-5p | Osteosarcoma | MNDR-E-MI-21187 |
| MNDR | hsa-miR-186-5p | Inclusion body myositis | MNDR-E-MI-21188 |
| MNDR | hsa-miR-186-5p | Meningioma | MNDR-E-MI-21189 |
| MNDR | hsa-miR-186-5p | Uterine cancer | MNDR-E-MI-21190 |
| MNDR | hsa-miR-186-5p | Gastric adenocarcinoma | MNDR-E-MI-21191 |
| MNDR | hsa-miR-186-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21192 |
| MNDR | hsa-miR-186-5p | Pituitary adenoma | MNDR-E-MI-21193 |
| MNDR | hsa-miR-186-5p | Lung squamous cell carcinoma | MNDR-E-MI-21194 |
| MNDR | hsa-miR-186-5p | Lung adenocarcinoma | MNDR-E-MI-21195 |
| MNDR | hsa-miR-186-5p | Thyroid carcinoma | MNDR-E-MI-21196 |
| MNDR | hsa-miR-186-5p | Pancreatic adenocarcinoma | MNDR-E-MI-21197 |
| MNDR | hsa-miR-186-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-21198 |
| MNDR | hsa-miR-186-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21199 |
| MNDR | hsa-miR-186-5p | Renal clear cell carcinoma | MNDR-E-MI-21200 |
| MNDR | hsa-miR-186-5p | Cholangiocarcinoma | MNDR-E-MI-21201 |
| MNDR | hsa-miR-186-5p | Esophageal cancer | MNDR-E-MI-21202 |
| MNDR | hsa-miR-186-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21203 |
| MNDR | hsa-miR-186-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-21204 |
| MNDR | hsa-miR-186-5p | Breast invasive carcinoma | MNDR-E-MI-21205 |
| MNDR | hsa-miR-186-5p | Hepatocellular carcinoma | MNDR-E-MI-21206 |
| MNDR | hsa-miR-186-5p | Familiar ovarian carcinoma | MNDR-E-MI-21207 |
| MNDR | hsa-miR-186-5p | B-cell lymphoma | MNDR-E-MI-21208 |
| MNDR | hsa-miR-186-5p | Rheumatoid arthritis | MNDR-E-MI-21209 |
| MNDR | hsa-miR-186-5p | Retinoblastoma | MNDR-E-MI-21210 |
| MNDR | hsa-miR-186-5p | Hodgkin lymphoma | MNDR-E-MI-21211 |
| MNDR | hsa-miR-186-5p | Tonsil cancer | MNDR-E-MI-21212 |
| MNDR | hsa-miR-186-5p | Neuromyelitis optica | MNDR-E-MI-21213 |
| MNDR | hsa-miR-186-5p | Skin cutaneous melanoma | MNDR-E-MI-21214 |
| MNDR | hsa-miR-186-5p | Skin melanoma | MNDR-E-MI-21215 |
| MNDR | hsa-miR-186-5p | Colorectal cancer | MNDR-E-MI-21216 |
| MNDR | hsa-miR-186-5p | Multiple myeloma | MNDR-E-MI-21217 |
| MNDR | hsa-miR-186-5p | Prostatic neoplasms | MNDR-E-MI-21218 |
| MNDR | hsa-miR-186-5p | Hypersomnolence idiopathic | MNDR-E-MI-21219 |
| MNDR | hsa-miR-186-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-21220 |
| MNDR | hsa-miR-186-5p | Stroke lacunar | MNDR-E-MI-21221 |
| MNDR | hsa-miR-186-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-21222 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022776 |
TOP